Will CTI BioPharma Corp (CTIC) Outperform the Rest of the Stocks in the Healthcare Sector?

Friday, June 23, 2023 01:07 PM | InvestorsObserver Analysts

Mentioned in this article

Will CTI BioPharma Corp (CTIC) Outperform the Rest of the Stocks in the Healthcare Sector?

CTI BioPharma Corp (CTIC) is near the top in its sector according to InvestorsObserver. CTIC gets an overall rating of 93. That means it scores higher than 93% of stocks. CTI BioPharma Corp gets a 90 rank in the Healthcare sector. Healthcare is number 2 out of 11 sectors.

CTIC has an Overall Score of 93. Find out what this means to you and get the rest of the rankings on CTIC!

See Full CTIC Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 93 means the stock is more attractive than 93 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With CTI BioPharma Corp Stock Today?

CTI BioPharma Corp (CTIC) stock is unchanged 0% while the S&P 500 is lower by -0.49% as of 12:54 PM on Friday, Jun 23. CTIC is unmoved $0.00 from the previous closing price of $9.09 on volume of 3,576,662 shares. Over the past year the S&P 500 is higher by 14.87% while CTIC is up 52.52%. CTIC lost -$0.58 per share the over the last 12 months. Click Here to get the full Stock Report for CTI BioPharma Corp stock.